Chronic Low Back Pain Market By Diagnosis (X-Ray, Computerized Tomography (CT), Myelograms, Discography, MRI, Electrodiagnostics, Bone Scans, Ultrasound Imaging and Others); By End Users (Hospitals, Clinics, Ambulatory Surgical Centers, and Others); By Treatment (Analgesic Medications, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anticonvulsants, Antidepressants, Counter-Irritants); By Surgery (Vertebroplasty and kyphoplasty, Spinal Laminectomy, Discectomy or microdisectomy, Foraminotomy, Intradiscal electrothermal theraphy (IDET), Spinal fusion, Artificial disc replacement and Others); By Region (U.S., Canada, Mexico, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027
Industry Trends
In terms of revenue, the global chronic low back pain market stood at US$ 6429.30 Mn in 2018 and is anticipated to reach US$ 10012.52 Mn by 2027, expanding at a CAGR of 4.8% over the next eight years. Growing share of ageing population across several regions combined with sedentary lifestyle and obesity are the primary causative factors modifying the overall chronic low back pain market. Amongst these, it has been reported that sedentary lifestyle is the primary reason for the global industry growth. Sometimes, when a weekday routine of getting too little exercise is compensated by a strenuous weekend workout, it can develop chronic pain on the lower back.
A recent study highlights that the high cost of diagnosis and treatment of chronic lower back pain is leading to burn in the pockets of patients which is leading to Chronic Low Back Pain Market. According to the American Chiropractic Association report, America spends approximately USD 50,000 million in health care for the low-back pain each year .These findings are alarming, considering the socio-economic impact of chronic low back pain. Health care stakeholders are aiming to solve the current challenges and to build a sustainable foundation for affordable, accessible, high-quality chronic low back pain treatment.
Procedures such as minimally invasive injections is used for managing chronic low back pain conditions. The epidural steroid injections during minimally invasive pain treatment helps in reducing inflammation and pain that is usually accompanied with it. The steroid injected is a good option for patients suffering from degenerative disc disease, spinal stenosis and herniated discs. The minimal-invasive pain treatments also includes facet joint injections, medial branch blocks, trigger point injections , viscoelastic hyaluronate injections, stem cell concentrate (PRP and/or BMAC) injections and radiofrequency ablation of nerves. Other treatment methods duly includes acupuncture, nutritional therapy, dry needling, and magnets usage amongst others. Such factors are expected to propel the global Chronic Low Back Pain Market growth in the future years.
The medication market segment have several providers who have formulations with expiring patents. This proves an opportunity for pharmaceutical companies to venture into the market targeting particular medication types for future growth. The Chronic Low Back Pain Market has barriers to entry which include the required technical expertise for creation of new formulations, and related regulatory infrastructure, limiting companies with newer formulations to venture into the market. Thus, the threat of new entrants is rated as low to moderate.
The types of medications used for treating chronic low back pain are analgesic medications, nonsteroidal anti-inflammatory drugs, counter irritants, antidepressants and anticonvulsants. Acetaminophen remains one of the best first-line treatments of chronic low back pain. Analgesic medications held the largest share in 2018 and is expected to continue the same trend over the forecast period. This particular medication group are specifically designed to relieve pain. Analgesic medications include prescription opioids such as oxycodone, morphine, codeine and hydrocodone as well as OTC acetaminophen and aspirin.
North America accounted the largest penetration in Chronic Low Back Pain Market 2018 owing to the prevalence of inflammatory back pain conditions amongst the United States adults. Pain management programs such as Functional Restoration (FR) were introduced for chronic low back pain patients facing debilitating effects related to an overall “pain syndrome”. The interdisciplinary approach is basically aimed at customizing the treatment options in order to promote maximum rehabilitation in both psychological and physical areas. This is primarily achieved by using a combination of cognitive behavioral therapy (CBT), psychosocial evaluations and physical conditioning that are in turn carefully monitored by a team of experienced health-care professionals. The same has shown highly effective in terms of therapeutic application. Other forms of physical modalities includes chiropractic care, myofascial-release therapy and exercise.
North America Chronic Low Back Pain Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of chronic low back pain market, as well as provides comprehensive insights and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings, specification, pricing, and gross margin.
Key players operating in the global chronic low back pain market are Astellas Pharma Inc., Grunenthal GmbH, Orion Oyj, Pfizer Inc., Regeneron Pharmaceuticals, Inc, Array BioPharma Inc., Egale Corporation, Gador S.A. Kineta., Inc, MEDRx Co., Ltd amongst others.
Chronic Low Back Pain Market:
- By Diagnosis
- X-Ray
- Computerized Tomography (CT)
- Myelograms
- Discography
- MRI
- Electrodiagnostics
- Bone Scans
- Ultrasound Imaging
- Others
- By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- By Treatment
- Analgesic Medications
- Non-Steroidal Anti-Inflammatory Drugs
- Anticonvulsants
- Antidepressants
- Counter Irritants
- By Surgery
- Vertebroplasty and Kyphoplasty
- Spinal Laminectomy
- Disectomy or Microdiscectomy
- Foraminotomy
- Intradiscal Electrothermal Theraphy (IDET)
- Spinal Fusion
- Artificial Disc Replacement
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base Year:
2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid Databases
3.2.2. Secondary
Sources
3.3. Market Size
Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Chronic Low Back Pain Market
6. Market
Synopsis: Chronic Low Back Pain Market
7. Chronic Low
Back Pain Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Chronic Low Back Pain Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Chronic Low Back Pain Market
7.6. Porter’s Five
Force Analysis
7.7. PESTEL
Analysis
8. Global
Chronic Low Back Pain Market Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global Chronic
Low Back Pain Market Revenue (US$ Mn)
8.2. Global Chronic
Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Diagnosis
8.2.1. X Ray
8.2.1.1.
Definition
8.2.1.2.
Market Estimation and Penetration, 2015 – 2018
8.2.1.3.
Market Forecast, 2019 – 2027
8.2.1.4.
Compound Annual Growth Rate (CAGR)
8.2.1.5.
Regional Bifurcation
8.2.1.5.1.
North America
8.2.1.5.1.1.
Market Estimation, 2015 – 2018
8.2.1.5.1.2.
Market Forecast, 2019 – 2027
8.2.1.5.2.
Europe
8.2.1.5.2.1.
Market Estimation, 2015 – 2018
8.2.1.5.2.2.
Market Forecast, 2019 – 2027
8.2.1.5.3.
Asia Pacific
8.2.1.5.3.1.
Market Estimation, 2015 – 2018
8.2.1.5.3.2.
Market Forecast, 2019 – 2027
8.2.1.5.4.
Middle East and Africa
8.2.1.5.4.1.
Market Estimation, 2015 – 2018
8.2.1.5.4.2.
Market Forecast, 2019 – 2027
8.2.1.5.5.
Latin America
8.2.1.5.5.1.
Market Estimation, 2015 – 2018
8.2.1.5.5.2.
Market Forecast, 2019 – 2027
8.2.2. Computerized
Tomography (CT)
8.2.2.1.
Definition
8.2.2.2.
Market Estimation and Penetration, 2015 – 2018
8.2.2.3.
Market Forecast, 2019 – 2027
8.2.2.4.
Compound Annual Growth Rate (CAGR)
8.2.2.5.
Regional Bifurcation
8.2.2.5.1.
North America
8.2.2.5.1.1.
Market Estimation, 2015 – 2018
8.2.2.5.1.2.
Market Forecast, 2019 – 2027
8.2.2.5.2.
Europe
8.2.2.5.2.1.
Market Estimation, 2015 – 2018
8.2.2.5.2.2.
Market Forecast, 2019 – 2027
8.2.2.5.3.
Asia Pacific
8.2.2.5.3.1.
Market Estimation, 2015 – 2018
8.2.2.5.3.2.
Market Forecast, 2019 – 2027
8.2.2.5.4.
Middle East and Africa
8.2.2.5.4.1.
Market Estimation, 2015 – 2018
8.2.2.5.4.2.
Market Forecast, 2019 – 2027
8.2.2.5.5.
Latin America
8.2.2.5.5.1.
Market Estimation, 2015 – 2018
8.2.2.5.5.2.
Market Forecast, 2019 – 2027
8.2.3. Myelograms
8.2.3.1.
Definition
8.2.3.2.
Market Estimation and Penetration, 2015 – 2018
8.2.3.3.
Market Forecast, 2019 – 2027
8.2.3.4.
Compound Annual Growth Rate (CAGR)
8.2.3.5.
Regional Bifurcation
8.2.3.5.1.
North America
8.2.3.5.1.1.
Market Estimation, 2015 – 2018
8.2.3.5.1.2.
Market Forecast, 2019 – 2027
8.2.3.5.2.
Europe
8.2.3.5.2.1.
Market Estimation, 2015 – 2018
8.2.3.5.2.2.
Market Forecast, 2019 – 2027
8.2.3.5.3.
Asia Pacific
8.2.3.5.3.1.
Market Estimation, 2015 – 2018
8.2.3.5.3.2.
Market Forecast, 2019 – 2027
8.2.3.5.4.
Middle East and Africa
8.2.3.5.4.1.
Market Estimation, 2015 – 2018
8.2.3.5.4.2.
Market Forecast, 2019 – 2027
8.2.3.5.5.
Latin America
8.2.3.5.5.1.
Market Estimation, 2015 – 2018
8.2.3.5.5.2.
Market Forecast, 2019 – 2027
8.2.4. Discography
8.2.4.1.
Definition
8.2.4.2.
Market Estimation and Penetration, 2015 – 2018
8.2.4.3.
Market Forecast, 2019 – 2027
8.2.4.4.
Compound Annual Growth Rate (CAGR)
8.2.4.5.
Regional Bifurcation
8.2.4.5.1.
North America
8.2.4.5.1.1.
Market Estimation, 2015 – 2018
8.2.4.5.1.2.
Market Forecast, 2019 – 2027
8.2.4.5.2.
Europe
8.2.4.5.2.1.
Market Estimation, 2015 – 2018
8.2.4.5.2.2.
Market Forecast, 2019 – 2027
8.2.4.5.3.
Asia Pacific
8.2.4.5.3.1.
Market Estimation, 2015 – 2018
8.2.4.5.3.2.
Market Forecast, 2019 – 2027
8.2.4.5.4.
Middle East and Africa
8.2.4.5.4.1.
Market Estimation, 2015 – 2018
8.2.4.5.4.2.
Market Forecast, 2019 – 2027
8.2.4.5.5.
Latin America
8.2.4.5.5.1.
Market Estimation, 2015 – 2018
8.2.4.5.5.2.
Market Forecast, 2019 – 2027
8.2.5. MRI
8.2.5.1.
Definition
8.2.5.2.
Market Estimation and Penetration, 2015 – 2018
8.2.5.3.
Market Forecast, 2019 – 2027
8.2.5.4.
Compound Annual Growth Rate (CAGR)
8.2.5.5.
Regional Bifurcation
8.2.5.5.1.
North America
8.2.5.5.1.1.
Market Estimation, 2015 – 2018
8.2.5.5.1.2.
Market Forecast, 2019 – 2027
8.2.5.5.2.
Europe
8.2.5.5.2.1.
Market Estimation, 2015 – 2018
8.2.5.5.2.2.
Market Forecast, 2019 – 2027
8.2.5.5.3.
Asia Pacific
8.2.5.5.3.1.
Market Estimation, 2015 – 2018
8.2.5.5.3.2.
Market Forecast, 2019 – 2027
8.2.5.5.4.
Middle East and Africa
8.2.5.5.4.1.
Market Estimation, 2015 – 2018
8.2.5.5.4.2.
Market Forecast, 2019 – 2027
8.2.5.5.5.
Latin America
8.2.5.5.5.1.
Market Estimation, 2015 – 2018
8.2.5.5.5.2.
Market Forecast, 2019 – 2027
8.2.6. Electrodiagnostics
8.2.6.1.
Definition
8.2.6.2.
Market Estimation and Penetration, 2015 – 2018
8.2.6.3.
Market Forecast, 2019 – 2027
8.2.6.4.
Compound Annual Growth Rate (CAGR)
8.2.6.5.
Regional Bifurcation
8.2.6.5.1.
North America
8.2.6.5.1.1.
Market Estimation, 2015 – 2018
8.2.6.5.1.2.
Market Forecast, 2019 – 2027
8.2.6.5.2.
Europe
8.2.6.5.2.1.
Market Estimation, 2015 – 2018
8.2.6.5.2.2.
Market Forecast, 2019 – 2027
8.2.6.5.3.
Asia Pacific
8.2.6.5.3.1.
Market Estimation, 2015 – 2018
8.2.6.5.3.2.
Market Forecast, 2019 – 2027
8.2.6.5.4.
Middle East and Africa
8.2.6.5.4.1.
Market Estimation, 2015 – 2018
8.2.6.5.4.2.
Market Forecast, 2019 – 2027
8.2.6.5.5.
Latin America
8.2.6.5.5.1.
Market Estimation, 2015 – 2018
8.2.6.5.5.2.
Market Forecast, 2019 – 2027
8.2.7. Bone Scans
8.2.7.1.
Definition
8.2.7.2.
Market Estimation and Penetration, 2015 – 2018
8.2.7.3.
Market Forecast, 2019 – 2027
8.2.7.4.
Compound Annual Growth Rate (CAGR)
8.2.7.5.
Regional Bifurcation
8.2.7.5.1.
North America
8.2.7.5.1.1.
Market Estimation, 2015 – 2018
8.2.7.5.1.2.
Market Forecast, 2019 – 2027
8.2.7.5.2.
Europe
8.2.7.5.2.1.
Market Estimation, 2015 – 2018
8.2.7.5.2.2.
Market Forecast, 2019 – 2027
8.2.7.5.3.
Asia Pacific
8.2.7.5.3.1.
Market Estimation, 2015 – 2018
8.2.7.5.3.2.
Market Forecast, 2019 – 2027
8.2.7.5.4.
Middle East and Africa
8.2.7.5.4.1.
Market Estimation, 2015 – 2018
8.2.7.5.4.2.
Market Forecast, 2019 – 2027
8.2.7.5.5.
Latin America
8.2.7.5.5.1.
Market Estimation, 2015 – 2018
8.2.7.5.5.2.
Market Forecast, 2019 – 2027
8.2.8. Ultrasound
Imaging
8.2.8.1.
Definition
8.2.8.2.
Market Estimation and Penetration, 2015 – 2018
8.2.8.3.
Market Forecast, 2019 – 2027
8.2.8.4.
Compound Annual Growth Rate (CAGR)
8.2.8.5.
Regional Bifurcation
8.2.8.5.1.
North America
8.2.8.5.1.1.
Market Estimation, 2015 – 2018
8.2.8.5.1.2.
Market Forecast, 2019 – 2027
8.2.8.5.2.
Europe
8.2.8.5.2.1.
Market Estimation, 2015 – 2018
8.2.8.5.2.2.
Market Forecast, 2019 – 2027
8.2.8.5.3.
Asia Pacific
8.2.8.5.3.1.
Market Estimation, 2015 – 2018
8.2.8.5.3.2.
Market Forecast, 2019 – 2027
8.2.8.5.4.
Middle East and Africa
8.2.8.5.4.1.
Market Estimation, 2015 – 2018
8.2.8.5.4.2.
Market Forecast, 2019 – 2027
8.2.8.5.5.
Latin America
8.2.8.5.5.1.
Market Estimation, 2015 – 2018
8.2.8.5.5.2.
Market Forecast, 2019 – 2027
8.2.9. Others
8.2.9.1.
Definition
8.2.9.2.
Market Estimation and Penetration, 2015 – 2018
8.2.9.3.
Market Forecast, 2019 – 2027
8.2.9.4.
Compound Annual Growth Rate (CAGR)
8.2.9.5.
Regional Bifurcation
8.2.9.5.1.
North America
8.2.9.5.1.1.
Market Estimation, 2015 – 2018
8.2.9.5.1.2.
Market Forecast, 2019 – 2027
8.2.9.5.2.
Europe
8.2.9.5.2.1.
Market Estimation, 2015 – 2018
8.2.9.5.2.2.
Market Forecast, 2019 – 2027
8.2.9.5.3.
Asia Pacific
8.2.9.5.3.1.
Market Estimation, 2015 – 2018
8.2.9.5.3.2.
Market Forecast, 2019 – 2027
8.2.9.5.4.
Middle East and Africa
8.2.9.5.4.1.
Market Estimation, 2015 – 2018
8.2.9.5.4.2.
Market Forecast, 2019 – 2027
8.2.9.5.5.
Latin America
8.2.9.5.5.1.
Market Estimation, 2015 – 2018
8.2.9.5.5.2.
Market Forecast, 2019 – 2027
8.3. Key Segment
for Channeling Investments
8.3.1. By Diagnosis
9. Global
Chronic Low Back Pain Market Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global Chronic
Low Back Pain Market Revenue (US$ Mn) and Forecasts, By End User
9.2.1. Hospitals
9.2.1.1.
Definition
9.2.1.2.
Market Estimation and Penetration, 2015 – 2018
9.2.1.3.
Market Forecast, 2019 – 2027
9.2.1.4.
Compound Annual Growth Rate (CAGR)
9.2.1.5.
Regional Bifurcation
9.2.1.5.1.
North America
9.2.1.5.1.1.
Market Estimation, 2015 – 2018
9.2.1.5.1.2.
Market Forecast, 2019 – 2027
9.2.1.5.2.
Europe
9.2.1.5.2.1.
Market Estimation, 2015 – 2018
9.2.1.5.2.2.
Market Forecast, 2019 – 2027
9.2.1.5.3.
Asia Pacific
9.2.1.5.3.1.
Market Estimation, 2015 – 2018
9.2.1.5.3.2.
Market Forecast, 2019 – 2027
9.2.1.5.4.
Middle East and Africa
9.2.1.5.4.1.
Market Estimation, 2015 – 2018
9.2.1.5.4.2.
Market Forecast, 2019 – 2027
9.2.1.5.5.
Latin America
9.2.1.5.5.1.
Market Estimation, 2015 – 2018
9.2.1.5.5.2.
Market Forecast, 2019 – 2027
9.2.2. Clinics
9.2.2.1.
Definition
9.2.2.2.
Market Estimation and Penetration, 2015 – 2018
9.2.2.3.
Market Forecast, 2019 – 2027
9.2.2.4.
Compound Annual Growth Rate (CAGR)
9.2.2.5.
Regional Bifurcation
9.2.2.5.1.
North America
9.2.2.5.1.1.
Market Estimation, 2015 – 2018
9.2.2.5.1.2.
Market Forecast, 2019 – 2027
9.2.2.5.2.
Europe
9.2.2.5.2.1.
Market Estimation, 2015 – 2018
9.2.2.5.2.2.
Market Forecast, 2019 – 2027
9.2.2.5.3.
Asia Pacific
9.2.2.5.3.1.
Market Estimation, 2015 – 2018
9.2.2.5.3.2.
Market Forecast, 2019 – 2027
9.2.2.5.4.
Middle East and Africa
9.2.2.5.4.1.
Market Estimation, 2015 – 2018
9.2.2.5.4.2.
Market Forecast, 2019 – 2027
9.2.2.5.5.
Latin America
9.2.2.5.5.1.
Market Estimation, 2015 – 2018
9.2.2.5.5.2.
Market Forecast, 2019 – 2027
9.2.3. Ambulatory
Surgical Centers
9.2.3.1.
Definition
9.2.3.2.
Market Estimation and Penetration, 2015 – 2018
9.2.3.3.
Market Forecast, 2019 – 2027
9.2.3.4.
Compound Annual Growth Rate (CAGR)
9.2.3.5.
Regional Bifurcation
9.2.3.5.1.
North America
9.2.3.5.1.1.
Market Estimation, 2015 – 2018
9.2.3.5.1.2.
Market Forecast, 2019 – 2027
9.2.3.5.2.
Europe
9.2.3.5.2.1.
Market Estimation, 2015 – 2018
9.2.3.5.2.2.
Market Forecast, 2019 – 2027
9.2.3.5.3.
Asia Pacific
9.2.3.5.3.1.
Market Estimation, 2015 – 2018
9.2.3.5.3.2.
Market Forecast, 2019 – 2027
9.2.3.5.4.
Middle East and Africa
9.2.3.5.4.1.
Market Estimation, 2015 – 2018
9.2.3.5.4.2.
Market Forecast, 2019 – 2027
9.2.3.5.5.
Latin America
9.2.3.5.5.1.
Market Estimation, 2015 – 2018
9.2.3.5.5.2.
Market Forecast, 2019 – 2027
9.2.4. Others
9.2.4.1.
Definition
9.2.4.2.
Market Estimation and Penetration, 2015 – 2018
9.2.4.3.
Market Forecast, 2019 – 2027
9.2.4.4.
Compound Annual Growth Rate (CAGR)
9.2.4.5.
Regional Bifurcation
9.2.4.5.1.
North America
9.2.4.5.1.1.
Market Estimation, 2015 – 2018
9.2.4.5.1.2.
Market Forecast, 2019 – 2027
9.2.4.5.2.
Europe
9.2.4.5.2.1.
Market Estimation, 2015 – 2018
9.2.4.5.2.2.
Market Forecast, 2019 – 2027
9.2.4.5.3.
Asia Pacific
9.2.4.5.3.1.
Market Estimation, 2015 – 2018
9.2.4.5.3.2.
Market Forecast, 2019 – 2027
9.2.4.5.4.
Middle East and Africa
9.2.4.5.4.1.
Market Estimation, 2015 – 2018
9.2.4.5.4.2.
Market Forecast, 2019 – 2027
9.2.4.5.5.
Latin America
9.2.4.5.5.1.
Market Estimation, 2015 – 2018
9.2.4.5.5.2.
Market Forecast, 2019 – 2027
9.3. Key Segment
for Channeling Investments
9.3.1. By End User
10. Global
Chronic Low Back Pain Market Analysis and Forecasts, 2019 – 2027
10.1. Overview
10.2. Global Chronic
Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Treatment
10.2.1.
Analgesic Medications
10.2.1.1.
Definition
10.2.1.2.
Market Estimation and Penetration, 2015 – 2018
10.2.1.3.
Market Forecast, 2019 – 2027
10.2.1.4.
Compound Annual Growth Rate (CAGR)
10.2.1.5.
Regional Bifurcation
10.2.1.5.1.
North America
10.2.1.5.1.1.
Market Estimation, 2015 – 2018
10.2.1.5.1.2.
Market Forecast, 2019 – 2027
10.2.1.5.2.
Europe
10.2.1.5.2.1.
Market Estimation, 2015 – 2018
10.2.1.5.2.2.
Market Forecast, 2019 – 2027
10.2.1.5.3.
Asia Pacific
10.2.1.5.3.1.
Market Estimation, 2015 – 2018
10.2.1.5.3.2.
Market Forecast, 2019 – 2027
10.2.1.5.4.
Middle East and Africa
10.2.1.5.4.1.
Market Estimation, 2015 – 2018
10.2.1.5.4.2.
Market Forecast, 2019 – 2027
10.2.1.5.5.
Latin America
10.2.1.5.5.1.
Market Estimation, 2015 – 2018
10.2.1.5.5.2.
Market Forecast, 2019 – 2027
10.2.2.
Non-Steroidal Anti-Inflammatory Drugs
10.2.2.1.
Definition
10.2.2.2.
Market Estimation and Penetration, 2015 – 2018
10.2.2.3.
Market Forecast, 2019 – 2027
10.2.2.4.
Compound Annual Growth Rate (CAGR)
10.2.2.5.
Regional Bifurcation
10.2.2.5.1.
North America
10.2.2.5.1.1.
Market Estimation, 2015 – 2018
10.2.2.5.1.2.
Market Forecast, 2019 – 2027
10.2.2.5.2.
Europe
10.2.2.5.2.1.
Market Estimation, 2015 – 2018
10.2.2.5.2.2.
Market Forecast, 2019 – 2027
10.2.2.5.3.
Asia Pacific
10.2.2.5.3.1.
Market Estimation, 2015 – 2018
10.2.2.5.3.2.
Market Forecast, 2019 – 2027
10.2.2.5.4.
Middle East and Africa
10.2.2.5.4.1.
Market Estimation, 2015 – 2018
10.2.2.5.4.2.
Market Forecast, 2019 – 2027
10.2.2.5.5.
Latin America
10.2.2.5.5.1.
Market Estimation, 2015 – 2018
10.2.2.5.5.2.
Market Forecast, 2019 – 2027
10.2.3.
Anticonvulsants
10.2.3.1.
Definition
10.2.3.2.
Market Estimation and Penetration, 2015 – 2018
10.2.3.3.
Market Forecast, 2019 – 2027
10.2.3.4.
Compound Annual Growth Rate (CAGR)
10.2.3.5.
Regional Bifurcation
10.2.3.5.1.
North America
10.2.3.5.1.1.
Market Estimation, 2015 – 2018
10.2.3.5.1.2.
Market Forecast, 2019 – 2027
10.2.3.5.2.
Europe
10.2.3.5.2.1.
Market Estimation, 2015 – 2018
10.2.3.5.2.2.
Market Forecast, 2019 – 2027
10.2.3.5.3.
Asia Pacific
10.2.3.5.3.1.
Market Estimation, 2015 – 2018
10.2.3.5.3.2.
Market Forecast, 2019 – 2027
10.2.3.5.4.
Middle East and Africa
10.2.3.5.4.1.
Market Estimation, 2015 – 2018
10.2.3.5.4.2.
Market Forecast, 2019 – 2027
10.2.3.5.5.
Latin America
10.2.3.5.5.1.
Market Estimation, 2015 – 2018
10.2.3.5.5.2.
Market Forecast, 2019 – 2027
10.2.4.
Antidepressants
10.2.4.1.
Definition
10.2.4.2.
Market Estimation and Penetration, 2015 – 2018
10.2.4.3.
Market Forecast, 2019 – 2027
10.2.4.4.
Compound Annual Growth Rate (CAGR)
10.2.4.5.
Regional Bifurcation
10.2.4.5.1.
North America
10.2.4.5.1.1.
Market Estimation, 2015 – 2018
10.2.4.5.1.2.
Market Forecast, 2019 – 2027
10.2.4.5.2.
Europe
10.2.4.5.2.1.
Market Estimation, 2015 – 2018
10.2.4.5.2.2.
Market Forecast, 2019 – 2027
10.2.4.5.3.
Asia Pacific
10.2.4.5.3.1.
Market Estimation, 2015 – 2018
10.2.4.5.3.2.
Market Forecast, 2019 – 2027
10.2.4.5.4.
Middle East and Africa
10.2.4.5.4.1.
Market Estimation, 2015 – 2018
10.2.4.5.4.2.
Market Forecast, 2019 – 2027
10.2.4.5.5.
Latin America
10.2.4.5.5.1.
Market Estimation, 2015 – 2018
10.2.4.5.5.2.
Market Forecast, 2019 – 2027
10.2.5.
Counter Irritants
10.2.5.1.
Definition
10.2.5.2.
Market Estimation and Penetration, 2015 – 2018
10.2.5.3.
Market Forecast, 2019 – 2027
10.2.5.4.
Compound Annual Growth Rate (CAGR)
10.2.5.5.
Regional Bifurcation
10.2.5.5.1.
North America
10.2.5.5.1.1.
Market Estimation, 2015 – 2018
10.2.5.5.1.2.
Market Forecast, 2019 – 2027
10.2.5.5.2.
Europe
10.2.5.5.2.1.
Market Estimation, 2015 – 2018
10.2.5.5.2.2.
Market Forecast, 2019 – 2027
10.2.5.5.3.
Asia Pacific
10.2.5.5.3.1.
Market Estimation, 2015 – 2018
10.2.5.5.3.2.
Market Forecast, 2019 – 2027
10.2.5.5.4.
Middle East and Africa
10.2.5.5.4.1.
Market Estimation, 2015 – 2018
10.2.5.5.4.2.
Market Forecast, 2019 – 2027
10.2.5.5.5.
Latin America
10.2.5.5.5.1.
Market Estimation, 2015 – 2018
10.2.5.5.5.2.
Market Forecast, 2019 – 2027
10.3. Key Segment
for Channeling Investments
10.3.1.
By Treatment
11. Global
Chronic Low Back Pain Market Analysis and Forecasts, 2019 – 2027
11.1. Overview
11.2. Global Chronic
Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Surgery
11.2.1.
Vertebroplasty and Kyphoplasty
11.2.1.1.
Definition
11.2.1.2.
Market Estimation and Penetration, 2015 – 2018
11.2.1.3.
Market Forecast, 2019 – 2027
11.2.1.4.
Compound Annual Growth Rate (CAGR)
11.2.1.5.
Regional Bifurcation
11.2.1.5.1.
North America
11.2.1.5.1.1.
Market Estimation, 2015 – 2018
11.2.1.5.1.2.
Market Forecast, 2019 – 2027
11.2.1.5.2.
Europe
11.2.1.5.2.1.
Market Estimation, 2015 – 2018
11.2.1.5.2.2.
Market Forecast, 2019 – 2027
11.2.1.5.3.
Asia Pacific
11.2.1.5.3.1.
Market Estimation, 2015 – 2018
11.2.1.5.3.2.
Market Forecast, 2019 – 2027
11.2.1.5.4.
Middle East and Africa
11.2.1.5.4.1.
Market Estimation, 2015 – 2018
11.2.1.5.4.2.
Market Forecast, 2019 – 2027
11.2.1.5.5.
Latin America
11.2.1.5.5.1.
Market Estimation, 2015 – 2018
11.2.1.5.5.2.
Market Forecast, 2019 – 2027
11.2.2.
Spinal Laminectomy
11.2.2.1.
Definition
11.2.2.2.
Market Estimation and Penetration, 2015 – 2018
11.2.2.3.
Market Forecast, 2019 – 2027
11.2.2.4.
Compound Annual Growth Rate (CAGR)
11.2.2.5.
Regional Bifurcation
11.2.2.5.1.
North America
11.2.2.5.1.1.
Market Estimation, 2015 – 2018
11.2.2.5.1.2.
Market Forecast, 2019 – 2027
11.2.2.5.2.
Europe
11.2.2.5.2.1.
Market Estimation, 2015 – 2018
11.2.2.5.2.2.
Market Forecast, 2019 – 2027
11.2.2.5.3.
Asia Pacific
11.2.2.5.3.1.
Market Estimation, 2015 – 2018
11.2.2.5.3.2.
Market Forecast, 2019 – 2027
11.2.2.5.4.
Middle East and Africa
11.2.2.5.4.1.
Market Estimation, 2015 – 2018
11.2.2.5.4.2.
Market Forecast, 2019 – 2027
11.2.2.5.5.
Latin America
11.2.2.5.5.1.
Market Estimation, 2015 – 2018
11.2.2.5.5.2.
Market Forecast, 2019 – 2027
11.2.3.
Disectomy or Microdiscectomy
11.2.3.1.
Definition
11.2.3.2.
Market Estimation and Penetration, 2015 – 2018
11.2.3.3.
Market Forecast, 2019 – 2027
11.2.3.4.
Compound Annual Growth Rate (CAGR)
11.2.3.5.
Regional Bifurcation
11.2.3.5.1.
North America
11.2.3.5.1.1.
Market Estimation, 2015 – 2018
11.2.3.5.1.2.
Market Forecast, 2019 – 2027
11.2.3.5.2.
Europe
11.2.3.5.2.1.
Market Estimation, 2015 – 2018
11.2.3.5.2.2.
Market Forecast, 2019 – 2027
11.2.3.5.3.
Asia Pacific
11.2.3.5.3.1.
Market Estimation, 2015 – 2018
11.2.3.5.3.2.
Market Forecast, 2019 – 2027
11.2.3.5.4.
Middle East and Africa
11.2.3.5.4.1.
Market Estimation, 2015 – 2018
11.2.3.5.4.2.
Market Forecast, 2019 – 2027
11.2.3.5.5.
Latin America
11.2.3.5.5.1.
Market Estimation, 2015 – 2018
11.2.3.5.5.2.
Market Forecast, 2019 – 2027
11.2.4.
Foraminotomy
11.2.4.1.
Definition
11.2.4.2.
Market Estimation and Penetration, 2015 – 2018
11.2.4.3.
Market Forecast, 2019 – 2027
11.2.4.4.
Compound Annual Growth Rate (CAGR)
11.2.4.5.
Regional Bifurcation
11.2.4.5.1.
North America
11.2.4.5.1.1.
Market Estimation, 2015 – 2018
11.2.4.5.1.2.
Market Forecast, 2019 – 2027
11.2.4.5.2.
Europe
11.2.4.5.2.1.
Market Estimation, 2015 – 2018
11.2.4.5.2.2.
Market Forecast, 2019 – 2027
11.2.4.5.3.
Asia Pacific
11.2.4.5.3.1.
Market Estimation, 2015 – 2018
11.2.4.5.3.2.
Market Forecast, 2019 – 2027
11.2.4.5.4.
Middle East and Africa
11.2.4.5.4.1.
Market Estimation, 2015 – 2018
11.2.4.5.4.2.
Market Forecast, 2019 – 2027
11.2.4.5.5.
Latin America
11.2.4.5.5.1.
Market Estimation, 2015 – 2018
11.2.4.5.5.2.
Market Forecast, 2019 – 2027
11.2.5.
Intradiscal Electrothermal Theraphy (IDET)
11.2.5.1.
Definition
11.2.5.2.
Market Estimation and Penetration, 2015 – 2018
11.2.5.3.
Market Forecast, 2019 – 2027
11.2.5.4.
Compound Annual Growth Rate (CAGR)
11.2.5.5.
Regional Bifurcation
11.2.5.5.1.
North America
11.2.5.5.1.1.
Market Estimation, 2015 – 2018
11.2.5.5.1.2.
Market Forecast, 2019 – 2027
11.2.5.5.2.
Europe
11.2.5.5.2.1.
Market Estimation, 2015 – 2018
11.2.5.5.2.2.
Market Forecast, 2019 – 2027
11.2.5.5.3.
Asia Pacific
11.2.5.5.3.1.
Market Estimation, 2015 – 2018
11.2.5.5.3.2.
Market Forecast, 2019 – 2027
11.2.5.5.4.
Middle East and Africa
11.2.5.5.4.1.
Market Estimation, 2015 – 2018
11.2.5.5.4.2.
Market Forecast, 2019 – 2027
11.2.5.5.5.
Latin America
11.2.5.5.5.1.
Market Estimation, 2015 – 2018
11.2.5.5.5.2.
Market Forecast, 2019 – 2027
11.2.6.
Spinal Fusion
11.2.6.1.
Definition
11.2.6.2.
Market Estimation and Penetration, 2015 – 2018
11.2.6.3.
Market Forecast, 2019 – 2027
11.2.6.4.
Compound Annual Growth Rate (CAGR)
11.2.6.5.
Regional Bifurcation
11.2.6.5.1.
North America
11.2.6.5.1.1.
Market Estimation, 2015 – 2018
11.2.6.5.1.2.
Market Forecast, 2019 – 2027
11.2.6.5.2.
Europe
11.2.6.5.2.1.
Market Estimation, 2015 – 2018
11.2.6.5.2.2.
Market Forecast, 2019 – 2027
11.2.6.5.3.
Asia Pacific
11.2.6.5.3.1.
Market Estimation, 2015 – 2018
11.2.6.5.3.2.
Market Forecast, 2019 – 2027
11.2.6.5.4.
Middle East and Africa
11.2.6.5.4.1.
Market Estimation, 2015 – 2018
11.2.6.5.4.2.
Market Forecast, 2019 – 2027
11.2.6.5.5.
Latin America
11.2.6.5.5.1.
Market Estimation, 2015 – 2018
11.2.6.5.5.2.
Market Forecast, 2019 – 2027
11.2.7.
Artificial Disc Replacement
11.2.7.1.
Definition
11.2.7.2.
Market Estimation and Penetration, 2015 – 2018
11.2.7.3.
Market Forecast, 2019 – 2027
11.2.7.4.
Compound Annual Growth Rate (CAGR)
11.2.7.5.
Regional Bifurcation
11.2.7.5.1.
North America
11.2.7.5.1.1.
Market Estimation, 2015 – 2018
11.2.7.5.1.2.
Market Forecast, 2019 – 2027
11.2.7.5.2.
Europe
11.2.7.5.2.1.
Market Estimation, 2015 – 2018
11.2.7.5.2.2.
Market Forecast, 2019 – 2027
11.2.7.5.3.
Asia Pacific
11.2.7.5.3.1.
Market Estimation, 2015 – 2018
11.2.7.5.3.2.
Market Forecast, 2019 – 2027
11.2.7.5.4.
Middle East and Africa
11.2.7.5.4.1.
Market Estimation, 2015 – 2018
11.2.7.5.4.2.
Market Forecast, 2019 – 2027
11.2.7.5.5.
Latin America
11.2.7.5.5.1.
Market Estimation, 2015 – 2018
11.2.7.5.5.2.
Market Forecast, 2019 – 2027
11.2.8.
Others
11.2.8.1.
Definition
11.2.8.2.
Market Estimation and Penetration, 2015 – 2018
11.2.8.3.
Market Forecast, 2019 – 2027
11.2.8.4.
Compound Annual Growth Rate (CAGR)
11.2.8.5.
Regional Bifurcation
11.2.8.5.1.
North America
11.2.8.5.1.1.
Market Estimation, 2015 – 2018
11.2.8.5.1.2.
Market Forecast, 2019 – 2027
11.2.8.5.2.
Europe
11.2.8.5.2.1.
Market Estimation, 2015 – 2018
11.2.8.5.2.2.
Market Forecast, 2019 – 2027
11.2.8.5.3.
Asia Pacific
11.2.8.5.3.1.
Market Estimation, 2015 – 2018
11.2.8.5.3.2.
Market Forecast, 2019 – 2027
11.2.8.5.4.
Middle East and Africa
11.2.8.5.4.1.
Market Estimation, 2015 – 2018
11.2.8.5.4.2.
Market Forecast, 2019 – 2027
11.2.8.5.5.
Latin America
11.2.8.5.5.1.
Market Estimation, 2015 – 2018
11.2.8.5.5.2.
Market Forecast, 2019 – 2027
11.3. Key Segment
for Channeling Investments
11.3.1.
By Surgery
12. North America
Chronic Low Back Pain Market Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1.
North America Chronic Low Back Pain Market Revenue (US$ Mn)
12.2. North America
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Diagnosis
12.2.1.
X Ray
12.2.2.
Computerized Tomography (CT)
12.2.3.
Myelograms
12.2.4.
Discography
12.2.5.
MRI
12.2.6.
Electrodiagnostics
12.2.7.
Bone Scans
12.2.8.
Ultrasound Imaging
12.2.9.
Others
12.3. North America
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By End User
12.3.1.
Hospitals
12.3.2.
Clinics
12.3.3.
Ambulatory Surgical Centers
12.3.4.
Others
12.4. North America
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Treatment
12.4.1.
Analgesic Medications
12.4.2.
Non-Steroidal Anti-Inflammatory Drugs
12.4.3.
Anticonvulsants
12.4.4.
Antidepressants
12.4.5.
Counter Irritants
12.5. North America
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Surgery
12.5.1.
Vertebroplasty and Kyphoplasty
12.5.2.
Spinal Laminectomy
12.5.3.
Disectomy or Microdiscectomy
12.5.4.
Foraminotomy
12.5.5.
Intradiscal Electrothermal Theraphy (IDET)
12.5.6.
Spinal Fusion
12.5.7.
Artificial Disc Replacement
12.5.8.
Others
12.6. North America
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1.
U.S
12.6.1.1.
U.S Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
12.6.1.1.1.
X Ray
12.6.1.1.2.
Computerized Tomography (CT)
12.6.1.1.3.
Myelograms
12.6.1.1.4.
Discography
12.6.1.1.5.
MRI
12.6.1.1.6.
Electrodiagnostics
12.6.1.1.7.
Bone Scans
12.6.1.1.8.
Ultrasound Imaging
12.6.1.1.9.
Others
12.6.1.2.
U.S Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.1.2.1.
Hospitals
12.6.1.2.2.
Clinics
12.6.1.2.3.
Ambulatory Surgical Centers
12.6.1.2.4.
Others
12.6.1.3.
U.S Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
12.6.1.3.1.
Analgesic Medications
12.6.1.3.2.
Non-Steroidal Anti-Inflammatory Drugs
12.6.1.3.3.
Anticonvulsants
12.6.1.3.4.
Antidepressants
12.6.1.3.5.
Counter Irritants
12.6.1.4.
U.S Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
12.6.1.4.1.
Vertebroplasty and Kyphoplasty
12.6.1.4.2.
Spinal Laminectomy
12.6.1.4.3.
Disectomy or Microdiscectomy
12.6.1.4.4.
Foraminotomy
12.6.1.4.5.
Intradiscal Electrothermal Theraphy (IDET)
12.6.1.4.6.
Spinal Fusion
12.6.1.4.7.
Artificial Disc Replacement
12.6.1.4.8.
Others
12.6.2.
Canada
12.6.2.1.
Canada Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
12.6.2.1.1.
X Ray
12.6.2.1.2.
Computerized Tomography (CT)
12.6.2.1.3.
Myelograms
12.6.2.1.4.
Discography
12.6.2.1.5.
MRI
12.6.2.1.6.
Electrodiagnostics
12.6.2.1.7.
Bone Scans
12.6.2.1.8.
Ultrasound Imaging
12.6.2.1.9.
Others
12.6.2.2.
Canada Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.2.2.1.
Hospitals
12.6.2.2.2.
Clinics
12.6.2.2.3.
Ambulatory Surgical Centers
12.6.2.2.4.
Others
12.6.2.3.
Canada Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
12.6.2.3.1.
Analgesic Medications
12.6.2.3.2.
Non-Steroidal Anti-Inflammatory Drugs
12.6.2.3.3.
Anticonvulsants
12.6.2.3.4.
Antidepressants
12.6.2.3.5.
Counter Irritants
12.6.2.4.
Canada Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
12.6.2.4.1.
Vertebroplasty and Kyphoplasty
12.6.2.4.2.
Spinal Laminectomy
12.6.2.4.3.
Disectomy or Microdiscectomy
12.6.2.4.4.
Foraminotomy
12.6.2.4.5.
Intradiscal Electrothermal Theraphy (IDET)
12.6.2.4.6.
Spinal Fusion
12.6.2.4.7.
Artificial Disc Replacement
12.6.2.4.8.
Others
12.6.3.
Mexico
12.6.3.1.
Mexico Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
12.6.3.1.1.
X Ray
12.6.3.1.2.
Computerized Tomography (CT)
12.6.3.1.3.
Myelograms
12.6.3.1.4.
Discography
12.6.3.1.5.
MRI
12.6.3.1.6.
Electrodiagnostics
12.6.3.1.7.
Bone Scans
12.6.3.1.8.
Ultrasound Imaging
12.6.3.1.9.
Others
12.6.3.2.
Mexico Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.3.2.1.
Hospitals
12.6.3.2.2.
Clinics
12.6.3.2.3.
Ambulatory Surgical Centers
12.6.3.2.4.
Others
12.6.3.3.
Mexico Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
12.6.3.3.1.
Analgesic Medications
12.6.3.3.2.
Non-Steroidal Anti-Inflammatory Drugs
12.6.3.3.3.
Anticonvulsants
12.6.3.3.4.
Antidepressants
12.6.3.3.5.
Counter Irritants
12.6.3.4.
Mexico Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
12.6.3.4.1.
Vertebroplasty and Kyphoplasty
12.6.3.4.2.
Spinal Laminectomy
12.6.3.4.3.
Disectomy or Microdiscectomy
12.6.3.4.4.
Foraminotomy
12.6.3.4.5.
Intradiscal Electrothermal Theraphy (IDET)
12.6.3.4.6.
Spinal Fusion
12.6.3.4.7.
Artificial Disc Replacement
12.6.3.4.8.
Others
12.6.4.
Rest of North America
12.6.4.1.
Rest of North America Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By Diagnosis
12.6.4.1.1.
X Ray
12.6.4.1.2.
Computerized Tomography (CT)
12.6.4.1.3.
Myelograms
12.6.4.1.4.
Discography
12.6.4.1.5.
MRI
12.6.4.1.6.
Electrodiagnostics
12.6.4.1.7.
Bone Scans
12.6.4.1.8.
Ultrasound Imaging
12.6.4.1.9.
Others
12.6.4.2.
Rest of North America Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By End User
12.6.4.2.1.
Hospitals
12.6.4.2.2.
Clinics
12.6.4.2.3.
Ambulatory Surgical Centers
12.6.4.2.4.
Others
12.6.4.3.
Rest of North America Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By Treatment
12.6.4.3.1.
Analgesic Medications
12.6.4.3.2.
Non-Steroidal Anti-Inflammatory Drugs
12.6.4.3.3.
Anticonvulsants
12.6.4.3.4.
Antidepressants
12.6.4.3.5.
Counter Irritants
12.6.4.4.
Rest of North America Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By Surgery
12.6.4.4.1.
Vertebroplasty and Kyphoplasty
12.6.4.4.2.
Spinal Laminectomy
12.6.4.4.3.
Disectomy or Microdiscectomy
12.6.4.4.4.
Foraminotomy
12.6.4.4.5.
Intradiscal Electrothermal Theraphy (IDET)
12.6.4.4.6.
Spinal Fusion
12.6.4.4.7.
Artificial Disc Replacement
12.6.4.4.8.
Others
12.7. Key Segment
for Channeling Investments
12.7.1.
By Country
12.7.2.
By Diagnosis
12.7.3.
By End User
12.7.4.
By Treatment
12.7.5.
By Surgery
13. Europe
Chronic Low Back Pain Market Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1.
Europe Chronic Low Back Pain Market Revenue (US$ Mn)
13.2. Europe Chronic
Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.2.1.
X Ray
13.2.2.
Computerized Tomography (CT)
13.2.3.
Myelograms
13.2.4.
Discography
13.2.5.
MRI
13.2.6.
Electrodiagnostics
13.2.7.
Bone Scans
13.2.8.
Ultrasound Imaging
13.2.9.
Others
13.3. Europe Chronic
Low Back Pain Market Revenue (US$ Mn) and Forecasts, By End User
13.3.1.
Hospitals
13.3.2.
Clinics
13.3.3.
Ambulatory Surgical Centers
13.3.4.
Others
13.4. Europe Chronic
Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Treatment
13.4.1.
Analgesic Medications
13.4.2.
Non-Steroidal Anti-Inflammatory Drugs
13.4.3.
Anticonvulsants
13.4.4.
Antidepressants
13.4.5.
Counter Irritants
13.5. Europe Chronic
Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Surgery
13.5.1.
Vertebroplasty and Kyphoplasty
13.5.2.
Spinal Laminectomy
13.5.3.
Disectomy or Microdiscectomy
13.5.4.
Foraminotomy
13.5.5.
Intradiscal Electrothermal Theraphy (IDET)
13.5.6.
Spinal Fusion
13.5.7.
Artificial Disc Replacement
13.5.8.
Others
13.6. Europe Chronic
Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1.
France
13.6.1.1.
France Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
13.6.1.1.1.
X Ray
13.6.1.1.2.
Computerized Tomography (CT)
13.6.1.1.3.
Myelograms
13.6.1.1.4.
Discography
13.6.1.1.5.
MRI
13.6.1.1.6.
Electrodiagnostics
13.6.1.1.7.
Bone Scans
13.6.1.1.8.
Ultrasound Imaging
13.6.1.1.9.
Others
13.6.1.2.
France Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.1.2.1.
Hospitals
13.6.1.2.2.
Clinics
13.6.1.2.3.
Ambulatory Surgical Centers
13.6.1.2.4.
Others
13.6.1.3.
France Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
13.6.1.3.1.
Analgesic Medications
13.6.1.3.2.
Non-Steroidal Anti-Inflammatory Drugs
13.6.1.3.3.
Anticonvulsants
13.6.1.3.4.
Antidepressants
13.6.1.3.5.
Counter Irritants
13.6.1.4.
France Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
13.6.1.4.1.
Vertebroplasty and Kyphoplasty
13.6.1.4.2.
Spinal Laminectomy
13.6.1.4.3.
Disectomy or Microdiscectomy
13.6.1.4.4.
Foraminotomy
13.6.1.4.5.
Intradiscal Electrothermal Theraphy (IDET)
13.6.1.4.6.
Spinal Fusion
13.6.1.4.7.
Artificial Disc Replacement
13.6.1.4.8.
Others
13.6.2.
The UK
13.6.2.1.
The UK Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
13.6.2.1.1.
X Ray
13.6.2.1.2.
Computerized Tomography (CT)
13.6.2.1.3.
Myelograms
13.6.2.1.4.
Discography
13.6.2.1.5.
MRI
13.6.2.1.6.
Electrodiagnostics
13.6.2.1.7.
Bone Scans
13.6.2.1.8.
Ultrasound Imaging
13.6.2.1.9.
Others
13.6.2.2.
The UK Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.2.2.1.
Hospitals
13.6.2.2.2.
Clinics
13.6.2.2.3.
Ambulatory Surgical Centers
13.6.2.2.4.
Others
13.6.2.3.
The UK Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
13.6.2.3.1.
Analgesic Medications
13.6.2.3.2.
Non-Steroidal Anti-Inflammatory Drugs
13.6.2.3.3.
Anticonvulsants
13.6.2.3.4.
Antidepressants
13.6.2.3.5.
Counter Irritants
13.6.2.4.
The UK Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
13.6.2.4.1.
Vertebroplasty and Kyphoplasty
13.6.2.4.2.
Spinal Laminectomy
13.6.2.4.3.
Disectomy or Microdiscectomy
13.6.2.4.4.
Foraminotomy
13.6.2.4.5.
Intradiscal Electrothermal Theraphy (IDET)
13.6.2.4.6.
Spinal Fusion
13.6.2.4.7.
Artificial Disc Replacement
13.6.2.4.8.
Others
13.6.3.
Spain
13.6.3.1.
Spain Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
13.6.3.1.1.
X Ray
13.6.3.1.2.
Computerized Tomography (CT)
13.6.3.1.3.
Myelograms
13.6.3.1.4.
Discography
13.6.3.1.5.
MRI
13.6.3.1.6.
Electrodiagnostics
13.6.3.1.7.
Bone Scans
13.6.3.1.8.
Ultrasound Imaging
13.6.3.1.9.
Others
13.6.3.2.
Spain Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.3.2.1.
Hospitals
13.6.3.2.2.
Clinics
13.6.3.2.3.
Ambulatory Surgical Centers
13.6.3.2.4.
Others
13.6.3.3.
Spain Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
13.6.3.3.1.
Analgesic Medications
13.6.3.3.2.
Non-Steroidal Anti-Inflammatory Drugs
13.6.3.3.3.
Anticonvulsants
13.6.3.3.4.
Antidepressants
13.6.3.3.5.
Counter Irritants
13.6.3.4.
Spain Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
13.6.3.4.1.
Vertebroplasty and Kyphoplasty
13.6.3.4.2.
Spinal Laminectomy
13.6.3.4.3.
Disectomy or Microdiscectomy
13.6.3.4.4.
Foraminotomy
13.6.3.4.5.
Intradiscal Electrothermal Theraphy (IDET)
13.6.3.4.6.
Spinal Fusion
13.6.3.4.7.
Artificial Disc Replacement
13.6.3.4.8.
Others
13.6.4.
Germany
13.6.4.1.
Germany Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
13.6.4.1.1.
X Ray
13.6.4.1.2.
Computerized Tomography (CT)
13.6.4.1.3.
Myelograms
13.6.4.1.4.
Discography
13.6.4.1.5.
MRI
13.6.4.1.6.
Electrodiagnostics
13.6.4.1.7.
Bone Scans
13.6.4.1.8.
Ultrasound Imaging
13.6.4.1.9.
Others
13.6.4.2.
Germany Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.4.2.1.
Hospitals
13.6.4.2.2.
Clinics
13.6.4.2.3.
Ambulatory Surgical Centers
13.6.4.2.4.
Others
13.6.4.3.
Germany Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
13.6.4.3.1.
Analgesic Medications
13.6.4.3.2.
Non-Steroidal Anti-Inflammatory Drugs
13.6.4.3.3.
Anticonvulsants
13.6.4.3.4.
Antidepressants
13.6.4.3.5.
Counter Irritants
13.6.4.4.
Germany Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
13.6.4.4.1.
Vertebroplasty and Kyphoplasty
13.6.4.4.2.
Spinal Laminectomy
13.6.4.4.3.
Disectomy or Microdiscectomy
13.6.4.4.4.
Foraminotomy
13.6.4.4.5.
Intradiscal Electrothermal Theraphy (IDET)
13.6.4.4.6.
Spinal Fusion
13.6.4.4.7.
Artificial Disc Replacement
13.6.4.4.8.
Others
13.6.5.
Italy
13.6.5.1.
Italy Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
13.6.5.1.1.
X Ray
13.6.5.1.2.
Computerized Tomography (CT)
13.6.5.1.3.
Myelograms
13.6.5.1.4.
Discography
13.6.5.1.5.
MRI
13.6.5.1.6.
Electrodiagnostics
13.6.5.1.7.
Bone Scans
13.6.5.1.8.
Ultrasound Imaging
13.6.5.1.9.
Others
13.6.5.2.
Italy Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.5.2.1.
Hospitals
13.6.5.2.2.
Clinics
13.6.5.2.3.
Ambulatory Surgical Centers
13.6.5.2.4.
Others
13.6.5.3.
Italy Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
13.6.5.3.1.
Analgesic Medications
13.6.5.3.2.
Non-Steroidal Anti-Inflammatory Drugs
13.6.5.3.3.
Anticonvulsants
13.6.5.3.4.
Antidepressants
13.6.5.3.5.
Counter Irritants
13.6.5.4.
Italy Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
13.6.5.4.1.
Vertebroplasty and Kyphoplasty
13.6.5.4.2.
Spinal Laminectomy
13.6.5.4.3.
Disectomy or Microdiscectomy
13.6.5.4.4.
Foraminotomy
13.6.5.4.5.
Intradiscal Electrothermal Theraphy (IDET)
13.6.5.4.6.
Spinal Fusion
13.6.5.4.7.
Artificial Disc Replacement
13.6.5.4.8.
Others
13.6.6.
Nordic Countries
13.6.6.1.
Nordic Countries Chronic Low Back Pain Market Revenue (US$
Mn) and Forecasts, By Diagnosis
13.6.6.1.1.
X Ray
13.6.6.1.2.
Computerized Tomography (CT)
13.6.6.1.3.
Myelograms
13.6.6.1.4.
Discography
13.6.6.1.5.
MRI
13.6.6.1.6.
Electrodiagnostics
13.6.6.1.7.
Bone Scans
13.6.6.1.8.
Ultrasound Imaging
13.6.6.1.9.
Others
13.6.6.2.
Nordic Countries Chronic Low Back Pain Market Revenue (US$
Mn) and Forecasts, By End User
13.6.6.2.1.
Hospitals
13.6.6.2.2.
Clinics
13.6.6.2.3.
Ambulatory Surgical Centers
13.6.6.2.4.
Others
13.6.6.3.
Nordic Countries Chronic Low Back Pain Market Revenue (US$
Mn) and Forecasts, By Treatment
13.6.6.3.1.
Analgesic Medications
13.6.6.3.2.
Non-Steroidal Anti-Inflammatory Drugs
13.6.6.3.3.
Anticonvulsants
13.6.6.3.4.
Antidepressants
13.6.6.3.5.
Counter Irritants
13.6.6.4.
Nordic Countries Chronic Low Back Pain Market Revenue (US$
Mn) and Forecasts, By Surgery
13.6.6.4.1.
Vertebroplasty and Kyphoplasty
13.6.6.4.2.
Spinal Laminectomy
13.6.6.4.3.
Disectomy or Microdiscectomy
13.6.6.4.4.
Foraminotomy
13.6.6.4.5.
Intradiscal Electrothermal Theraphy (IDET)
13.6.6.4.6.
Spinal Fusion
13.6.6.4.7.
Artificial Disc Replacement
13.6.6.4.8.
Others
13.6.6.5.
Nordic Countries Chronic Low Back Pain Market Revenue (US$
Mn) and Forecasts, By Country
13.6.6.5.1.
Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4.
Sweden
13.6.6.5.5.
Norway
13.6.7.
Benelux Union
13.6.7.1.
Benelux Union Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Diagnosis
13.6.7.1.1.
X Ray
13.6.7.1.2.
Computerized Tomography (CT)
13.6.7.1.3.
Myelograms
13.6.7.1.4.
Discography
13.6.7.1.5.
MRI
13.6.7.1.6.
Electrodiagnostics
13.6.7.1.7.
Bone Scans
13.6.7.1.8.
Ultrasound Imaging
13.6.7.1.9.
Others
13.6.7.2.
Benelux Union Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.7.2.1.
Hospitals
13.6.7.2.2.
Clinics
13.6.7.2.3.
Ambulatory Surgical Centers
13.6.7.2.4.
Others
13.6.7.3.
Benelux Union Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Treatment
13.6.7.3.1.
Analgesic Medications
13.6.7.3.2.
Non-Steroidal Anti-Inflammatory Drugs
13.6.7.3.3.
Anticonvulsants
13.6.7.3.4.
Antidepressants
13.6.7.3.5.
Counter Irritants
13.6.7.4.
Benelux Union Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Surgery
13.6.7.4.1.
Vertebroplasty and Kyphoplasty
13.6.7.4.2.
Spinal Laminectomy
13.6.7.4.3.
Disectomy or Microdiscectomy
13.6.7.4.4.
Foraminotomy
13.6.7.4.5.
Intradiscal Electrothermal Theraphy (IDET)
13.6.7.4.6.
Spinal Fusion
13.6.7.4.7.
Artificial Disc Replacement
13.6.7.4.8.
Others
13.6.7.5.
Benelux Union Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
The Netherlands
13.6.7.5.3.
Luxembourg
13.6.8.
Rest of Europe
13.6.8.1.
Rest of Europe Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Diagnosis
13.6.8.1.1.
X Ray
13.6.8.1.2.
Computerized Tomography (CT)
13.6.8.1.3.
Myelograms
13.6.8.1.4.
Discography
13.6.8.1.5.
MRI
13.6.8.1.6.
Electrodiagnostics
13.6.8.1.7.
Bone Scans
13.6.8.1.8.
Ultrasound Imaging
13.6.8.1.9.
Others
13.6.8.2.
Rest of Europe Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.8.2.1.
Hospitals
13.6.8.2.2.
Clinics
13.6.8.2.3.
Ambulatory Surgical Centers
13.6.8.2.4.
Others
13.6.8.3.
Rest of Europe Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Treatment
13.6.8.3.1.
Analgesic Medications
13.6.8.3.2.
Non-Steroidal Anti-Inflammatory Drugs
13.6.8.3.3.
Anticonvulsants
13.6.8.3.4.
Antidepressants
13.6.8.3.5.
Counter Irritants
13.6.8.4.
Rest of Europe Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Surgery
13.6.8.4.1.
Vertebroplasty and Kyphoplasty
13.6.8.4.2.
Spinal Laminectomy
13.6.8.4.3.
Disectomy or Microdiscectomy
13.6.8.4.4.
Foraminotomy
13.6.8.4.5.
Intradiscal Electrothermal Theraphy (IDET)
13.6.8.4.6.
Spinal Fusion
13.6.8.4.7.
Artificial Disc Replacement
13.6.8.4.8.
Others
13.7. Key Segment
for Channeling Investments
13.7.1.
By Country
13.7.2.
By Diagnosis
13.7.3.
By End User
13.7.4.
By Treatment
13.7.5.
By Surgery
14. Asia Pacific
Chronic Low Back Pain Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1.
Asia Pacific Chronic Low Back Pain Market Revenue (US$ Mn)
14.2. Asia Pacific
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.2.1.
X Ray
14.2.2.
Computerized Tomography (CT)
14.2.3.
Myelograms
14.2.4.
Discography
14.2.5.
MRI
14.2.6.
Electrodiagnostics
14.2.7.
Bone Scans
14.2.8.
Ultrasound Imaging
14.2.9.
Others
14.3. Asia Pacific Chronic
Low Back Pain Market Revenue (US$ Mn) and Forecasts, By End User
14.3.1.
Hospitals
14.3.2.
Clinics
14.3.3.
Ambulatory Surgical Centers
14.3.4.
Others
14.4. Asia Pacific
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Treatment
14.4.1.
Analgesic Medications
14.4.2.
Non-Steroidal Anti-Inflammatory Drugs
14.4.3.
Anticonvulsants
14.4.4.
Antidepressants
14.4.5.
Counter Irritants
14.5. Asia Pacific
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Surgery
14.5.1.
Vertebroplasty and Kyphoplasty
14.5.2.
Spinal Laminectomy
14.5.3.
Disectomy or Microdiscectomy
14.5.4.
Foraminotomy
14.5.5.
Intradiscal Electrothermal Theraphy (IDET)
14.5.6.
Spinal Fusion
14.5.7.
Artificial Disc Replacement
14.5.8.
Others
14.6. Asia Pacific
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1.
China
14.6.1.1.
China Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
14.6.1.1.1.
X Ray
14.6.1.1.2.
Computerized Tomography (CT)
14.6.1.1.3.
Myelograms
14.6.1.1.4.
Discography
14.6.1.1.5.
MRI
14.6.1.1.6.
Electrodiagnostics
14.6.1.1.7.
Bone Scans
14.6.1.1.8.
Ultrasound Imaging
14.6.1.1.9.
Others
14.6.1.2.
China Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.1.2.1.
Hospitals
14.6.1.2.2.
Clinics
14.6.1.2.3.
Ambulatory Surgical Centers
14.6.1.2.4.
Others
14.6.1.3.
China Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
14.6.1.3.1.
Analgesic Medications
14.6.1.3.2.
Non-Steroidal Anti-Inflammatory Drugs
14.6.1.3.3.
Anticonvulsants
14.6.1.3.4.
Antidepressants
14.6.1.3.5.
Counter Irritants
14.6.1.4.
China Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
14.6.1.4.1.
Vertebroplasty and Kyphoplasty
14.6.1.4.2.
Spinal Laminectomy
14.6.1.4.3.
Disectomy or Microdiscectomy
14.6.1.4.4.
Foraminotomy
14.6.1.4.5.
Intradiscal Electrothermal Theraphy (IDET)
14.6.1.4.6.
Spinal Fusion
14.6.1.4.7.
Artificial Disc Replacement
14.6.1.4.8.
Others
14.6.2.
Japan
14.6.2.1.
Japan Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
14.6.2.1.1.
X Ray
14.6.2.1.2.
Computerized Tomography (CT)
14.6.2.1.3.
Myelograms
14.6.2.1.4.
Discography
14.6.2.1.5.
MRI
14.6.2.1.6.
Electrodiagnostics
14.6.2.1.7.
Bone Scans
14.6.2.1.8.
Ultrasound Imaging
14.6.2.1.9.
Others
14.6.2.2.
Japan Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.2.2.1.
Hospitals
14.6.2.2.2.
Clinics
14.6.2.2.3.
Ambulatory Surgical Centers
14.6.2.2.4.
Others
14.6.2.3.
Japan Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
14.6.2.3.1.
Analgesic Medications
14.6.2.3.2.
Non-Steroidal Anti-Inflammatory Drugs
14.6.2.3.3.
Anticonvulsants
14.6.2.3.4.
Antidepressants
14.6.2.3.5.
Counter Irritants
14.6.2.4.
Japan Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
14.6.2.4.1.
Vertebroplasty and Kyphoplasty
14.6.2.4.2.
Spinal Laminectomy
14.6.2.4.3.
Disectomy or Microdiscectomy
14.6.2.4.4.
Foraminotomy
14.6.2.4.5.
Intradiscal Electrothermal Theraphy (IDET)
14.6.2.4.6.
Spinal Fusion
14.6.2.4.7.
Artificial Disc Replacement
14.6.2.4.8.
Others
14.6.3.
India
14.6.3.1.
India Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
14.6.3.1.1.
X Ray
14.6.3.1.2.
Computerized Tomography (CT)
14.6.3.1.3.
Myelograms
14.6.3.1.4.
Discography
14.6.3.1.5.
MRI
14.6.3.1.6.
Electrodiagnostics
14.6.3.1.7.
Bone Scans
14.6.3.1.8.
Ultrasound Imaging
14.6.3.1.9.
Others
14.6.3.2.
India Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.3.2.1.
Hospitals
14.6.3.2.2.
Clinics
14.6.3.2.3.
Ambulatory Surgical Centers
14.6.3.2.4.
Others
14.6.3.3.
India Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
14.6.3.3.1.
Analgesic Medications
14.6.3.3.2.
Non-Steroidal Anti-Inflammatory Drugs
14.6.3.3.3.
Anticonvulsants
14.6.3.3.4.
Antidepressants
14.6.3.3.5.
Counter Irritants
14.6.3.4.
India Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
14.6.3.4.1.
Vertebroplasty and Kyphoplasty
14.6.3.4.2.
Spinal Laminectomy
14.6.3.4.3.
Disectomy or Microdiscectomy
14.6.3.4.4.
Foraminotomy
14.6.3.4.5.
Intradiscal Electrothermal Theraphy (IDET)
14.6.3.4.6.
Spinal Fusion
14.6.3.4.7.
Artificial Disc Replacement
14.6.3.4.8.
Others
14.6.4.
New Zealand
14.6.4.1.
New Zealand Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
14.6.4.1.1.
X Ray
14.6.4.1.2.
Computerized Tomography (CT)
14.6.4.1.3.
Myelograms
14.6.4.1.4.
Discography
14.6.4.1.5.
MRI
14.6.4.1.6.
Electrodiagnostics
14.6.4.1.7.
Bone Scans
14.6.4.1.8.
Ultrasound Imaging
14.6.4.1.9.
Others
14.6.4.2.
New Zealand Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.4.2.1.
Hospitals
14.6.4.2.2.
Clinics
14.6.4.2.3.
Ambulatory Surgical Centers
14.6.4.2.4.
Others
14.6.4.3.
New Zealand Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
14.6.4.3.1.
Analgesic Medications
14.6.4.3.2.
Non-Steroidal Anti-Inflammatory Drugs
14.6.4.3.3.
Anticonvulsants
14.6.4.3.4.
Antidepressants
14.6.4.3.5.
Counter Irritants
14.6.4.4.
New Zealand Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
14.6.4.4.1.
Vertebroplasty and Kyphoplasty
14.6.4.4.2.
Spinal Laminectomy
14.6.4.4.3.
Disectomy or Microdiscectomy
14.6.4.4.4.
Foraminotomy
14.6.4.4.5.
Intradiscal Electrothermal Theraphy (IDET)
14.6.4.4.6.
Spinal Fusion
14.6.4.4.7.
Artificial Disc Replacement
14.6.4.4.8.
Others
14.6.5.
Australia
14.6.5.1.
Australia Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
14.6.5.1.1.
X Ray
14.6.5.1.2.
Computerized Tomography (CT)
14.6.5.1.3.
Myelograms
14.6.5.1.4.
Discography
14.6.5.1.5.
MRI
14.6.5.1.6.
Electrodiagnostics
14.6.5.1.7.
Bone Scans
14.6.5.1.8.
Ultrasound Imaging
14.6.5.1.9.
Others
14.6.5.2.
Australia Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.5.2.1.
Hospitals
14.6.5.2.2.
Clinics
14.6.5.2.3.
Ambulatory Surgical Centers
14.6.5.2.4.
Others
14.6.5.3.
Australia Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
14.6.5.3.1.
Analgesic Medications
14.6.5.3.2.
Non-Steroidal Anti-Inflammatory Drugs
14.6.5.3.3.
Anticonvulsants
14.6.5.3.4.
Antidepressants
14.6.5.3.5.
Counter Irritants
14.6.5.4.
Australia Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
14.6.5.4.1.
Vertebroplasty and Kyphoplasty
14.6.5.4.2.
Spinal Laminectomy
14.6.5.4.3.
Disectomy or Microdiscectomy
14.6.5.4.4.
Foraminotomy
14.6.5.4.5.
Intradiscal Electrothermal Theraphy (IDET)
14.6.5.4.6.
Spinal Fusion
14.6.5.4.7.
Artificial Disc Replacement
14.6.5.4.8.
Others
14.6.6.
South Korea
14.6.6.1.
South Korea Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
14.6.6.1.1.
X Ray
14.6.6.1.2.
Computerized Tomography (CT)
14.6.6.1.3.
Myelograms
14.6.6.1.4.
Discography
14.6.6.1.5.
MRI
14.6.6.1.6.
Electrodiagnostics
14.6.6.1.7.
Bone Scans
14.6.6.1.8.
Ultrasound Imaging
14.6.6.1.9.
Others
14.6.6.2.
South Korea Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.6.2.1.
Hospitals
14.6.6.2.2.
Clinics
14.6.6.2.3.
Ambulatory Surgical Centers
14.6.6.2.4.
Others
14.6.6.3.
South Korea Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
14.6.6.3.1.
Analgesic Medications
14.6.6.3.2.
Non-Steroidal Anti-Inflammatory Drugs
14.6.6.3.3.
Anticonvulsants
14.6.6.3.4.
Antidepressants
14.6.6.3.5.
Counter Irritants
14.6.6.4.
South Korea Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
14.6.6.4.1.
Vertebroplasty and Kyphoplasty
14.6.6.4.2.
Spinal Laminectomy
14.6.6.4.3.
Disectomy or Microdiscectomy
14.6.6.4.4.
Foraminotomy
14.6.6.4.5.
Intradiscal Electrothermal Theraphy (IDET)
14.6.6.4.6.
Spinal Fusion
14.6.6.4.7.
Artificial Disc Replacement
14.6.6.4.8.
Others
14.6.7.
Southeast Asia
14.6.7.1.
Southeast Asia Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Diagnosis
14.6.7.1.1.
X Ray
14.6.7.1.2.
Computerized Tomography (CT)
14.6.7.1.3.
Myelograms
14.6.7.1.4.
Discography
14.6.7.1.5.
MRI
14.6.7.1.6.
Electrodiagnostics
14.6.7.1.7.
Bone Scans
14.6.7.1.8.
Ultrasound Imaging
14.6.7.1.9.
Others
14.6.7.2.
Southeast Asia Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.7.2.1.
Hospitals
14.6.7.2.2.
Clinics
14.6.7.2.3.
Ambulatory Surgical Centers
14.6.7.2.4.
Others
14.6.7.3.
Southeast Asia Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Treatment
14.6.7.3.1.
Analgesic Medications
14.6.7.3.2.
Non-Steroidal Anti-Inflammatory Drugs
14.6.7.3.3.
Anticonvulsants
14.6.7.3.4.
Antidepressants
14.6.7.3.5.
Counter Irritants
14.6.7.4.
Southeast Asia Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Surgery
14.6.7.4.1.
Vertebroplasty and Kyphoplasty
14.6.7.4.2.
Spinal Laminectomy
14.6.7.4.3.
Disectomy or Microdiscectomy
14.6.7.4.4.
Foraminotomy
14.6.7.4.5.
Intradiscal Electrothermal Theraphy (IDET)
14.6.7.4.6.
Spinal Fusion
14.6.7.4.7.
Artificial Disc Replacement
14.6.7.4.8.
Others
14.6.7.5.
Southeast Asia Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Country
14.6.7.5.1.
Indonesia
14.6.7.5.2.
Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of Southeast Asia
14.6.8.
Rest of Asia Pacific
14.6.8.1.
Rest of Asia Pacific Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By Diagnosis
14.6.8.1.1.
X Ray
14.6.8.1.2.
Computerized Tomography (CT)
14.6.8.1.3.
Myelograms
14.6.8.1.4.
Discography
14.6.8.1.5.
MRI
14.6.8.1.6.
Electrodiagnostics
14.6.8.1.7.
Bone Scans
14.6.8.1.8.
Ultrasound Imaging
14.6.8.1.9.
Others
14.6.8.2.
Rest of Asia Pacific Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By End User
14.6.8.2.1.
Hospitals
14.6.8.2.2.
Clinics
14.6.8.2.3.
Ambulatory Surgical Centers
14.6.8.2.4.
Others
14.6.8.3.
Rest of Asia Pacific Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By Treatment
14.6.8.3.1.
Analgesic Medications
14.6.8.3.2.
Non-Steroidal Anti-Inflammatory Drugs
14.6.8.3.3.
Anticonvulsants
14.6.8.3.4.
Antidepressants
14.6.8.3.5.
Counter Irritants
14.6.8.4.
Rest of Asia Pacific Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By Surgery
14.6.8.4.1.
Vertebroplasty and Kyphoplasty
14.6.8.4.2.
Spinal Laminectomy
14.6.8.4.3.
Disectomy or Microdiscectomy
14.6.8.4.4.
Foraminotomy
14.6.8.4.5.
Intradiscal Electrothermal Theraphy (IDET)
14.6.8.4.6.
Spinal Fusion
14.6.8.4.7.
Artificial Disc Replacement
14.6.8.4.8.
Others
14.7. Key Segment
for Channeling Investments
14.7.1.
By Country
14.7.2.
By Diagnosis
14.7.3.
By End User
14.7.4.
By Treatment
14.7.5.
By Surgery
15. Middle East
and Africa Chronic Low Back Pain Market Analysis and Forecasts, 2019 - 2027
15.1. Overview
15.1.1.
Middle East and Africa Chronic Low Back Pain Market Revenue
(US$ Mn)
15.2. Middle East
and Africa Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
15.2.1.
X Ray
15.2.2.
Computerized Tomography (CT)
15.2.3.
Myelograms
15.2.4.
Discography
15.2.5.
MRI
15.2.6.
Electrodiagnostics
15.2.7.
Bone Scans
15.2.8.
Ultrasound Imaging
15.2.9.
Others
15.3. Middle East
and Africa Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By End
User
15.3.1.
Hospitals
15.3.2.
Clinics
15.3.3.
Ambulatory Surgical Centers
15.3.4.
Others
15.4. Middle East
and Africa Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By
Treatment
15.4.1.
Analgesic Medications
15.4.2.
Non-Steroidal Anti-Inflammatory Drugs
15.4.3.
Anticonvulsants
15.4.4.
Antidepressants
15.4.5.
Counter Irritants
15.5. Middle East
and Africa Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By
Surgery
15.5.1.
Vertebroplasty and Kyphoplasty
15.5.2.
Spinal Laminectomy
15.5.3.
Disectomy or Microdiscectomy
15.5.4.
Foraminotomy
15.5.5.
Intradiscal Electrothermal Theraphy (IDET)
15.5.6.
Spinal Fusion
15.5.7.
Artificial Disc Replacement
15.5.8.
Others
15.6. Middle East
and Africa Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By
Country
15.6.1.
Saudi Arabia
15.6.1.1.
Saudi Arabia Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Diagnosis
15.6.1.1.1.
X Ray
15.6.1.1.2.
Computerized Tomography (CT)
15.6.1.1.3.
Myelograms
15.6.1.1.4.
Discography
15.6.1.1.5.
MRI
15.6.1.1.6.
Electrodiagnostics
15.6.1.1.7.
Bone Scans
15.6.1.1.8.
Ultrasound Imaging
15.6.1.1.9.
Others
15.6.1.2.
Saudi Arabia Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By End User
15.6.1.2.1.
Hospitals
15.6.1.2.2.
Clinics
15.6.1.2.3.
Ambulatory Surgical Centers
15.6.1.2.4.
Others
15.6.1.3.
Saudi Arabia Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Treatment
15.6.1.3.1.
Analgesic Medications
15.6.1.3.2.
Non-Steroidal Anti-Inflammatory Drugs
15.6.1.3.3.
Anticonvulsants
15.6.1.3.4.
Antidepressants
15.6.1.3.5.
Counter Irritants
15.6.1.4.
Saudi Arabia Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Surgery
15.6.1.4.1.
Vertebroplasty and Kyphoplasty
15.6.1.4.2.
Spinal Laminectomy
15.6.1.4.3.
Disectomy or Microdiscectomy
15.6.1.4.4.
Foraminotomy
15.6.1.4.5.
Intradiscal Electrothermal Theraphy (IDET)
15.6.1.4.6.
Spinal Fusion
15.6.1.4.7.
Artificial Disc Replacement
15.6.1.4.8.
Others
15.6.2.
UAE
15.6.2.1.
UAE Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
15.6.2.1.1.
X Ray
15.6.2.1.2.
Computerized Tomography (CT)
15.6.2.1.3.
Myelograms
15.6.2.1.4.
Discography
15.6.2.1.5.
MRI
15.6.2.1.6.
Electrodiagnostics
15.6.2.1.7.
Bone Scans
15.6.2.1.8.
Ultrasound Imaging
15.6.2.1.9.
Others
15.6.2.2.
UAE Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.2.2.1.
Hospitals
15.6.2.2.2.
Clinics
15.6.2.2.3.
Ambulatory Surgical Centers
15.6.2.2.4.
Others
15.6.2.3.
UAE Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
15.6.2.3.1.
Analgesic Medications
15.6.2.3.2.
Non-Steroidal Anti-Inflammatory Drugs
15.6.2.3.3.
Anticonvulsants
15.6.2.3.4.
Antidepressants
15.6.2.3.5.
Counter Irritants
15.6.2.4.
UAE Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
15.6.2.4.1.
Vertebroplasty and Kyphoplasty
15.6.2.4.2.
Spinal Laminectomy
15.6.2.4.3.
Disectomy or Microdiscectomy
15.6.2.4.4.
Foraminotomy
15.6.2.4.5.
Intradiscal Electrothermal Theraphy (IDET)
15.6.2.4.6.
Spinal Fusion
15.6.2.4.7.
Artificial Disc Replacement
15.6.2.4.8.
Others
15.6.3.
Egypt
15.6.3.1.
Egypt Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
15.6.3.1.1.
X Ray
15.6.3.1.2.
Computerized Tomography (CT)
15.6.3.1.3.
Myelograms
15.6.3.1.4.
Discography
15.6.3.1.5.
MRI
15.6.3.1.6.
Electrodiagnostics
15.6.3.1.7.
Bone Scans
15.6.3.1.8.
Ultrasound Imaging
15.6.3.1.9.
Others
15.6.3.2.
Egypt Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.3.2.1.
Hospitals
15.6.3.2.2.
Clinics
15.6.3.2.3.
Ambulatory Surgical Centers
15.6.3.2.4.
Others
15.6.3.3.
Egypt Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
15.6.3.3.1.
Analgesic Medications
15.6.3.3.2.
Non-Steroidal Anti-Inflammatory Drugs
15.6.3.3.3.
Anticonvulsants
15.6.3.3.4.
Antidepressants
15.6.3.3.5.
Counter Irritants
15.6.3.4.
Egypt Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
15.6.3.4.1.
Vertebroplasty and Kyphoplasty
15.6.3.4.2.
Spinal Laminectomy
15.6.3.4.3.
Disectomy or Microdiscectomy
15.6.3.4.4.
Foraminotomy
15.6.3.4.5.
Intradiscal Electrothermal Theraphy (IDET)
15.6.3.4.6.
Spinal Fusion
15.6.3.4.7.
Artificial Disc Replacement
15.6.3.4.8.
Others
15.6.4.
Kuwait
15.6.4.1.
Kuwait Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
15.6.4.1.1.
X Ray
15.6.4.1.2.
Computerized Tomography (CT)
15.6.4.1.3.
Myelograms
15.6.4.1.4.
Discography
15.6.4.1.5.
MRI
15.6.4.1.6.
Electrodiagnostics
15.6.4.1.7.
Bone Scans
15.6.4.1.8.
Ultrasound Imaging
15.6.4.1.9.
Others
15.6.4.2.
Kuwait Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.4.2.1.
Hospitals
15.6.4.2.2.
Clinics
15.6.4.2.3.
Ambulatory Surgical Centers
15.6.4.2.4.
Others
15.6.4.3.
Kuwait Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
15.6.4.3.1.
Analgesic Medications
15.6.4.3.2.
Non-Steroidal Anti-Inflammatory Drugs
15.6.4.3.3.
Anticonvulsants
15.6.4.3.4.
Antidepressants
15.6.4.3.5.
Counter Irritants
15.6.4.4.
Kuwait Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
15.6.4.4.1.
Vertebroplasty and Kyphoplasty
15.6.4.4.2.
Spinal Laminectomy
15.6.4.4.3.
Disectomy or Microdiscectomy
15.6.4.4.4.
Foraminotomy
15.6.4.4.5.
Intradiscal Electrothermal Theraphy (IDET)
15.6.4.4.6.
Spinal Fusion
15.6.4.4.7.
Artificial Disc Replacement
15.6.4.4.8.
Others
15.6.5.
South Africa
15.6.5.1.
South Africa Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Diagnosis
15.6.5.1.1.
X Ray
15.6.5.1.2.
Computerized Tomography (CT)
15.6.5.1.3.
Myelograms
15.6.5.1.4.
Discography
15.6.5.1.5.
MRI
15.6.5.1.6.
Electrodiagnostics
15.6.5.1.7.
Bone Scans
15.6.5.1.8.
Ultrasound Imaging
15.6.5.1.9.
Others
15.6.5.2.
South Africa Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By End User
15.6.5.2.1.
Hospitals
15.6.5.2.2.
Clinics
15.6.5.2.3.
Ambulatory Surgical Centers
15.6.5.2.4.
Others
15.6.5.3.
South Africa Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Treatment
15.6.5.3.1.
Analgesic Medications
15.6.5.3.2.
Non-Steroidal Anti-Inflammatory Drugs
15.6.5.3.3.
Anticonvulsants
15.6.5.3.4.
Antidepressants
15.6.5.3.5.
Counter Irritants
15.6.5.4.
South Africa Chronic Low Back Pain Market Revenue (US$ Mn)
and Forecasts, By Surgery
15.6.5.4.1.
Vertebroplasty and Kyphoplasty
15.6.5.4.2.
Spinal Laminectomy
15.6.5.4.3.
Disectomy or Microdiscectomy
15.6.5.4.4.
Foraminotomy
15.6.5.4.5.
Intradiscal Electrothermal Theraphy (IDET)
15.6.5.4.6.
Spinal Fusion
15.6.5.4.7.
Artificial Disc Replacement
15.6.5.4.8.
Others
15.6.6.
Rest of Middle East & Africa
15.6.6.1.
Rest of Middle East & Africa Chronic Low Back Pain Market
Revenue (US$ Mn) and Forecasts, By Diagnosis
15.6.6.1.1.
X Ray
15.6.6.1.2.
Computerized Tomography (CT)
15.6.6.1.3.
Myelograms
15.6.6.1.4.
Discography
15.6.6.1.5.
MRI
15.6.6.1.6.
Electrodiagnostics
15.6.6.1.7.
Bone Scans
15.6.6.1.8.
Ultrasound Imaging
15.6.6.1.9.
Others
15.6.6.2.
Rest of Middle East & Africa Chronic Low Back Pain Market
Revenue (US$ Mn) and Forecasts, By End User
15.6.6.2.1.
Hospitals
15.6.6.2.2.
Clinics
15.6.6.2.3.
Ambulatory Surgical Centers
15.6.6.2.4.
Others
15.6.6.3.
Rest of Middle East & Africa Chronic Low Back Pain Market
Revenue (US$ Mn) and Forecasts, By Treatment
15.6.6.3.1.
Analgesic Medications
15.6.6.3.2.
Non-Steroidal Anti-Inflammatory Drugs
15.6.6.3.3.
Anticonvulsants
15.6.6.3.4.
Antidepressants
15.6.6.3.5.
Counter Irritants
15.6.6.4.
Rest of Middle East & Africa Chronic Low Back Pain Market
Revenue (US$ Mn) and Forecasts, By Surgery
15.6.6.4.1.
Vertebroplasty and Kyphoplasty
15.6.6.4.2.
Spinal Laminectomy
15.6.6.4.3.
Disectomy or Microdiscectomy
15.6.6.4.4.
Foraminotomy
15.6.6.4.5.
Intradiscal Electrothermal Theraphy (IDET)
15.6.6.4.6.
Spinal Fusion
15.6.6.4.7.
Artificial Disc Replacement
15.6.6.4.8.
Others
15.7. Key Segment
for Channeling Investments
15.7.1.
By Country
15.7.2.
By Diagnosis
15.7.3.
By End User
15.7.4.
By Treatment
15.7.5.
By Surgery
16. Latin America
Chronic Low Back Pain Market Analysis and Forecasts, 2019 - 2027
16.1. Overview
16.1.1.
Latin America Chronic Low Back Pain Market Revenue (US$ Mn)
16.2. Latin America
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Diagnosis
16.2.1.
X Ray
16.2.2.
Computerized Tomography (CT)
16.2.3.
Myelograms
16.2.4.
Discography
16.2.5.
MRI
16.2.6.
Electrodiagnostics
16.2.7.
Bone Scans
16.2.8.
Ultrasound Imaging
16.2.9.
Others
16.3. Latin America
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By End User
16.3.1.
Hospitals
16.3.2.
Clinics
16.3.3.
Ambulatory Surgical Centers
16.3.4.
Others
16.4. Latin America
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Treatment
16.4.1.
Analgesic Medications
16.4.2.
Non-Steroidal Anti-Inflammatory Drugs
16.4.3.
Anticonvulsants
16.4.4.
Antidepressants
16.4.5.
Counter Irritants
16.5. Latin America
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Surgery
16.5.1.
Vertebroplasty and Kyphoplasty
16.5.2.
Spinal Laminectomy
16.5.3.
Disectomy or Microdiscectomy
16.5.4.
Foraminotomy
16.5.5.
Intradiscal Electrothermal Theraphy (IDET)
16.5.6.
Spinal Fusion
16.5.7.
Artificial Disc Replacement
16.5.8.
Others
16.6. Latin America
Chronic Low Back Pain Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1.
Brazil
16.6.1.1.
Brazil Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
16.6.1.1.1.
X Ray
16.6.1.1.2.
Computerized Tomography (CT)
16.6.1.1.3.
Myelograms
16.6.1.1.4.
Discography
16.6.1.1.5.
MRI
16.6.1.1.6.
Electrodiagnostics
16.6.1.1.7.
Bone Scans
16.6.1.1.8.
Ultrasound Imaging
16.6.1.1.9.
Others
16.6.1.2.
Brazil Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.1.2.1.
Hospitals
16.6.1.2.2.
Clinics
16.6.1.2.3.
Ambulatory Surgical Centers
16.6.1.2.4.
Others
16.6.1.3.
Brazil Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
16.6.1.3.1.
Analgesic Medications
16.6.1.3.2.
Non-Steroidal Anti-Inflammatory Drugs
16.6.1.3.3.
Anticonvulsants
16.6.1.3.4.
Antidepressants
16.6.1.3.5.
Counter Irritants
16.6.1.4.
Brazil Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
16.6.1.4.1.
Vertebroplasty and Kyphoplasty
16.6.1.4.2.
Spinal Laminectomy
16.6.1.4.3.
Disectomy or Microdiscectomy
16.6.1.4.4.
Foraminotomy
16.6.1.4.5.
Intradiscal Electrothermal Theraphy (IDET)
16.6.1.4.6.
Spinal Fusion
16.6.1.4.7.
Artificial Disc Replacement
16.6.1.4.8.
Others
16.6.2.
Argentina
16.6.2.1.
Argentina Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
16.6.2.1.1.
X Ray
16.6.2.1.2.
Computerized Tomography (CT)
16.6.2.1.3.
Myelograms
16.6.2.1.4.
Discography
16.6.2.1.5.
MRI
16.6.2.1.6.
Electrodiagnostics
16.6.2.1.7.
Bone Scans
16.6.2.1.8.
Ultrasound Imaging
16.6.2.1.9.
Others
16.6.2.2.
Argentina Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.2.2.1.
Hospitals
16.6.2.2.2.
Clinics
16.6.2.2.3.
Ambulatory Surgical Centers
16.6.2.2.4.
Others
16.6.2.3.
Argentina Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Treatment
16.6.2.3.1.
Analgesic Medications
16.6.2.3.2.
Non-Steroidal Anti-Inflammatory Drugs
16.6.2.3.3.
Anticonvulsants
16.6.2.3.4.
Antidepressants
16.6.2.3.5.
Counter Irritants
16.6.2.4.
Argentina Chronic Low Back Pain Market Revenue (US$ Mn) and
Forecasts, By Surgery
16.6.2.4.1.
Vertebroplasty and Kyphoplasty
16.6.2.4.2.
Spinal Laminectomy
16.6.2.4.3.
Disectomy or Microdiscectomy
16.6.2.4.4.
Foraminotomy
16.6.2.4.5.
Intradiscal Electrothermal Theraphy (IDET)
16.6.2.4.6.
Spinal Fusion
16.6.2.4.7.
Artificial Disc Replacement
16.6.2.4.8.
Others
16.6.3.
Rest of Latin America
16.6.3.1.
Rest of Latin America Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By Diagnosis
16.6.3.1.1.
X Ray
16.6.3.1.2.
Computerized Tomography (CT)
16.6.3.1.3.
Myelograms
16.6.3.1.4.
Discography
16.6.3.1.5.
MRI
16.6.3.1.6.
Electrodiagnostics
16.6.3.1.7.
Bone Scans
16.6.3.1.8.
Ultrasound Imaging
16.6.3.1.9.
Others
16.6.3.2.
Rest of Latin America Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By End User
16.6.3.2.1.
Hospitals
16.6.3.2.2.
Clinics
16.6.3.2.3.
Ambulatory Surgical Centers
16.6.3.2.4.
Others
16.6.3.3.
Rest of Latin America Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By Treatment
16.6.3.3.1.
Analgesic Medications
16.6.3.3.2.
Non-Steroidal Anti-Inflammatory Drugs
16.6.3.3.3.
Anticonvulsants
16.6.3.3.4.
Antidepressants
16.6.3.3.5.
Counter Irritants
16.6.3.4.
Rest of Latin America Chronic Low Back Pain Market Revenue
(US$ Mn) and Forecasts, By Surgery
16.6.3.4.1.
Vertebroplasty and Kyphoplasty
16.6.3.4.2.
Spinal Laminectomy
16.6.3.4.3.
Disectomy or Microdiscectomy
16.6.3.4.4.
Foraminotomy
16.6.3.4.5.
Intradiscal Electrothermal Theraphy (IDET)
16.6.3.4.6.
Spinal Fusion
16.6.3.4.7.
Artificial Disc Replacement
16.6.3.4.8.
Others
16.7. Key Segment
for Channeling Investments
16.7.1.
By Country
16.7.2.
By Diagnosis
16.7.3.
By End User
16.7.4.
By Treatment
16.7.5.
By Surgery
17. Competitive
Benchmarking
17.1. Market Share
Analysis, 2018
17.2. Global
Presence and Growth Strategies
17.2.1.
Mergers and Acquisitions
17.2.2.
Product Launches
17.2.3.
Investments Trends
17.2.4.
R&D Initiatives
18. Player
Profiles
18.1. Adynxx, Inc.
18.1.1.
Company Details
18.1.2.
Company Overview
18.1.3.
Product Offerings
18.1.4.
Key Developments
18.1.5.
Financial Analysis
18.1.6.
SWOT Analysis
18.1.7.
Business Strategies
18.2. Array
BioPharma Inc.
18.2.1.
Company Details
18.2.2.
Company Overview
18.2.3.
Product Offerings
18.2.4.
Key Developments
18.2.5.
Financial Analysis
18.2.6.
SWOT Analysis
18.2.7.
Business Strategies
18.3. Astellas
Pharma Inc.
18.3.1.
Company Details
18.3.2.
Company Overview
18.3.3.
Product Offerings
18.3.4.
Key Developments
18.3.5.
Financial Analysis
18.3.6.
SWOT Analysis
18.3.7.
Business Strategies
18.4. Axsome
Therapeutics
18.4.1.
Company Details
18.4.2.
Company Overview
18.4.3.
Product Offerings
18.4.4.
Key Developments
18.4.5.
Financial Analysis
18.4.6.
SWOT Analysis
18.4.7.
Business Strategies
18.5. Egalet
Corporation
18.5.1.
Company Details
18.5.2.
Company Overview
18.5.3.
Product Offerings
18.5.4.
Key Developments
18.5.5.
Financial Analysis
18.5.6.
SWOT Analysis
18.5.7.
Business Strategies
18.6. Frontier Biotechnologies
Co., Ltd
18.6.1.
Company Details
18.6.2.
Company Overview
18.6.3.
Product Offerings
18.6.4.
Key Developments
18.6.5.
Financial Analysis
18.6.6.
SWOT Analysis
18.6.7.
Business Strategies
18.7. Gador S.A.
Kineta.Inc
18.7.1.
Company Details
18.7.2.
Company Overview
18.7.3.
Product Offerings
18.7.4.
Key Developments
18.7.5.
Financial Analysis
18.7.6.
SWOT Analysis
18.7.7.
Business Strategies
18.8. Grunenthal
GmbH
18.8.1.
Company Details
18.8.2.
Company Overview
18.8.3.
Product Offerings
18.8.4.
Key Developments
18.8.5.
Financial Analysis
18.8.6.
SWOT Analysis
18.8.7.
Business Strategies
18.9. Hisamitsu
Pharmaceutical Co., Inc.
18.9.1.
Company Details
18.9.2.
Company Overview
18.9.3.
Product Offerings
18.9.4.
Key Developments
18.9.5.
Financial Analysis
18.9.6.
SWOT Analysis
18.9.7.
Business Strategies
18.10. Immune
Pharmaceutical Inc.
18.10.1.
Company Details
18.10.2.
Company Overview
18.10.3.
Product Offerings
18.10.4.
Key Developments
18.10.5.
Financial Analysis
18.10.6.
SWOT Analysis
18.10.7.
Business Strategies
18.11. MEDRx Co.,
Ltd.t
18.11.1.
Company Details
18.11.2.
Company Overview
18.11.3.
Product Offerings
18.11.4.
Key Developments
18.11.5.
Financial Analysis
18.11.6.
SWOT Analysis
18.11.7.
Business Strategies
18.12. MESOBLAST INC.
18.12.1.
Company Details
18.12.2.
Company Overview
18.12.3.
Product Offerings
18.12.4.
Key Developments
18.12.5.
Financial Analysis
18.12.6.
SWOT Analysis
18.12.7.
Business Strategies
18.13. Nektar
Therapeutics
18.13.1.
Company Details
18.13.2.
Company Overview
18.13.3.
Product Offerings
18.13.4.
Key Developments
18.13.5.
Financial Analysis
18.13.6.
SWOT Analysis
18.13.7.
Business Strategies
18.14. Norman
Interventional Pain Management
18.14.1.
Company Details
18.14.2.
Company Overview
18.14.3.
Product Offerings
18.14.4.
Key Developments
18.14.5.
Financial Analysis
18.14.6.
SWOT Analysis
18.14.7.
Business Strategies
18.15. Orion Oyj
18.15.1.
Company Details
18.15.2.
Company Overview
18.15.3.
Product Offerings
18.15.4.
Key Developments
18.15.5.
Financial Analysis
18.15.6.
SWOT Analysis
18.15.7.
Business Strategies
18.16. Pfizer Inc.
18.16.1.
Company Details
18.16.2.
Company Overview
18.16.3.
Product Offerings
18.16.4.
Key Developments
18.16.5.
Financial Analysis
18.16.6.
SWOT Analysis
18.16.7.
Business Strategies
18.17. Regeneron
Pharmaceuticals, Inc.
18.17.1.
Company Details
18.17.2.
Company Overview
18.17.3.
Product Offerings
18.17.4.
Key Developments
18.17.5.
Financial Analysis
18.17.6.
SWOT Analysis
18.17.7.
Business Strategies
18.18. Stayble
Therapeutics AB
18.18.1.
Company Details
18.18.2.
Company Overview
18.18.3.
Product Offerings
18.18.4.
Key Developments
18.18.5.
Financial Analysis
18.18.6.
SWOT Analysis
18.18.7.
Business Strategies
18.19. Other Market
Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
